Foghorn Therapeutics Inc.
Our corporate headquarters is in Cambridge, Massachusetts.
The Company is incorporated in Delaware.
Foghorn was founded in 2015.
Foghorn Therapeutics stock was listed on the NASDAQ Global Market under the ticker symbol FHTX. The Company’s Initial Public Offering was priced on 10/22/2020.
Foghorn Therapeutics fiscal year ends December 31st.
Deloitte & Touche LLP
200 Berkeley Street
Boston, Massachusetts 02116
Computershare Trust Company, N.A.
150 Royal Street
Canton, Massachusetts 02021
If you hold Foghorn stock in your own name, please contact our transfer agent, Computershare Trust Company, N.A. If you hold Foghorn stock in “street name,” please contact your securities broker.
Shares of Foghorn Therapeutics can be purchased through a securities broker of your choosing.
Please contact firstname.lastname@example.org at Foghorn Therapeutics for any additional Investor inquiries.
Company filings can be accessed via the SEC’s website by searching for
CIK Code: 0001822462
CUSIP number: 344174107